Food supplements: a better way to utilise the body’s microbiome? Stuart J. Ashman, CEO, and Dr Catherine O’Neill, CSO, SkinBioTherapeutics, investigate
Developed with NVIDIA, the platform also demonstrated high success in designing antimicrobial peptides targeting multidrug-resistant pathogens
Get breaking news, product releases, technical papers, innovation features, trend reports and live content agendas covering the entire industry.